Results 141 to 150 of about 80,362 (282)

The Management of Parkinson's Disease Before, during and after Pregnancy—an MDS Scientific Issues Committee Review

Movement Disorders Clinical Practice, Volume 13, Issue 1, Page 44-59, January 2026.
Abstract Background Pregnancy after a Parkinson's diagnosis presents complex challenges. Due to the paucity of literature, there is no evidence‐based guidelines and protocols for preconception care, management of pregnancy, childbirth and the postpartum period in women with early‐onset Parkinson's disease (PD).
Alexander C. Lehn, Jee‐Young Lee, Giorgia Sciacca, Stacy Patterson, Adam Morton, Paul Pun, Walaa A. Kamel, Marina Picillo, Bart Post, Eng‐King Tan, Tamine Capato, Bastiaan R. Bloem, Manon Auffret, Annelien M. Oosterbaan, Willanka Kapelle, Michiko K. Bruno, Lorraine V. Kalia, Jeffrey H. Kordower, Daniela Berg   +18 more
wiley   +1 more source

Verapamil in diabetes

Indian Journal of Endocrinology and Metabolism, 2017
Resham Raj Poudel, Nisha Kusum Kafle
openaire   +3 more sources

Uso do Verapamil em Gestantes Hipertensas Crônicas: Repercussão no Fluxo das Artérias Uterinas e Umbilical [PDF]

, 2000
Marcus José do Amaral Vasconcellos
openalex   +1 more source

Computational methods for visualizing and measuring verapamil efficacy for cerebral vasospasm [PDF]

, 2020
Andrew Abumoussa, Álex Flores, James Ho, Marc Niethammer, Deanna Sasaki‐Adams, Yueh Z. Lee   +5 more
openalex   +1 more source

A Review of Nanoparticle‐Based Astrocyte Modulation in CNS Disorders: Evaluating the Underexplored Potential of Intranasal Delivery

Nano Select, Volume 7, Issue 1, January 2026.
Nanoparticle‐driven nose‐to‐brain drug delivery offers a noninvasive approach to bypass the blood–brain barrier (BBB) and directly modulate reactive astrocytes in CNS disorders. This review highlights biodegradable nanoparticles for astrocyte modulation, enhancing drug bioavailability, sustained release, and neuroinflammation control.
Senamile M. Dlamini, Gillian D. Mahumane, Pradeep Kumar, Yahya E. Choonara   +3 more
wiley   +1 more source

HEMODYNAMIC CONTROL AFTER TRACHEAL INTUBATION: LIDOCAINE VS VERAPAMIL

Journal of Research in Medical Sciences, 2001
Introduction. Laryngoscopy and tracheal intubation cause sympathetic and parasympathetic stimulation that in turn, result in dangerous cardiovascular signs like elevation of systolic and diastolic blood pressure and heart rate.
M RAFIEI, J HASHEMI, P KASHEFI
doaj  

HALOTHANE—VERAPAMIL CAUSES REGIONAL MYOCARDIAL DYSFUNCTION IN THE DOG

, 1986
James G. Ramsay, G. R. Cutfield, C. M. Francis, William Devlin, D.P. FOËX   +4 more
openalex   +1 more source

Stress‐induced hemodynamic and hemostatic changes in patients with systemic hypertension: Effect of verapamil [PDF]

, 1996
Otávio Gebara, Alfredo H. Jimenez, Carol McKenna, Murray A. Mittleman, Ping Xu, Izabella Lipinska, James E. Muller, Geoffrey H. Tofler   +7 more
openalex   +1 more source

Physiologically‐Based Pharmacokinetic Modeling of the PARP Inhibitor Niraparib

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 1, January 2026.
ABSTRACT A physiologically‐based pharmacokinetic (PBPK) model of niraparib and its primary metabolite using a relevant virtual cancer population is reported here. A series of in vitro experiments using liver S9, microsomes, and hepatocytes with various inhibitors and recombinant supersomes demonstrated that niraparib is specifically metabolized by ...
Gareth J. Lewis, Roxanne C. Jewell, Anu Shilpa Krishnatry, Kunal S. Taskar   +3 more
wiley   +1 more source

Ventricular Tachycardia in the Absence of Structural Heart Disease [PDF]

, 2005
In up to 10% of patients who present with ventricular tachycardia (VT), obvious structural heart disease is not identified. In such patients, causes of ventricular arrhythmia include right ventricular outflow tract (RVOT) VT, extrasystoles, idiopathic ...
Appleton, Christopher P, Lester, Steven J, Munger, Thomas M, Scott, Luis R P, Srivathsan, Komandoor   +4 more
core   +1 more source